Logo image of OXBR

OXBRIDGE RE HOLDINGS LTD (OXBR) Stock Fundamental Analysis

NASDAQ:OXBR - Nasdaq - KYG6856M1069 - Common Stock - Currency: USD

1.75  -0.01 (-0.57%)

Fundamental Rating

2

Taking everything into account, OXBR scores 2 out of 10 in our fundamental rating. OXBR was compared to 144 industry peers in the Insurance industry. OXBR may be in some trouble as it scores bad on both profitability and health. OXBR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OXBR has reported negative net income.
OXBR had a negative operating cash flow in the past year.
In the past 5 years OXBR reported 4 times negative net income.
In the past 5 years OXBR always reported negative operating cash flow.
OXBR Yearly Net Income VS EBIT VS OCF VS FCFOXBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

OXBR has a Return On Assets of -19.10%. This is amonst the worse of the industry: OXBR underperforms 95.14% of its industry peers.
OXBR has a worse Return On Equity (-27.84%) than 90.97% of its industry peers.
Industry RankSector Rank
ROA -19.1%
ROE -27.84%
ROIC N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
OXBR Yearly ROA, ROE, ROICOXBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

OXBR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXBR Yearly Profit, Operating, Gross MarginsOXBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

OXBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OXBR has more shares outstanding
Compared to 5 years ago, OXBR has more shares outstanding
OXBR has a worse debt/assets ratio than last year.
OXBR Yearly Shares OutstandingOXBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
OXBR Yearly Total Debt VS Total AssetsOXBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

A Debt/Equity ratio of 0.02 indicates that OXBR is not too dependend on debt financing.
OXBR has a better Debt to Equity ratio (0.02) than 88.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.46%
OXBR Yearly LT Debt VS Equity VS FCFOXBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
OXBR Yearly Current Assets VS Current LiabilitesOXBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.87% over the past year.
OXBR shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.79%.
OXBR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.27% yearly.
EPS 1Y (TTM)82.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.67%
Revenue 1Y (TTM)33.79%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%630.77%

3.2 Future

The Earnings Per Share is expected to grow by 31.06% on average over the next years. This is a very strong growth
Based on estimates for the next years, OXBR will show a very strong growth in Revenue. The Revenue will grow by 42.82% on average per year.
EPS Next Y102.28%
EPS Next 2Y39.8%
EPS Next 3Y31.06%
EPS Next 5YN/A
Revenue Next Year10.64%
Revenue Next 2Y25.41%
Revenue Next 3Y42.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OXBR Yearly Revenue VS EstimatesOXBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
OXBR Yearly EPS VS EstimatesOXBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.02 -0.02 0.04 0.06 0.08 0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OXBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OXBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OXBR Price Earnings VS Forward Price EarningsOXBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXBR Per share dataOXBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as OXBR's earnings are expected to grow with 31.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.8%
EPS Next 3Y31.06%

More info and screens

0

5. Dividend

5.1 Amount

OXBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OXBRIDGE RE HOLDINGS LTD

NASDAQ:OXBR (6/27/2025, 8:00:02 PM)

1.75

-0.01 (-0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06
Inst Owners15.7%
Inst Owner Change136.98%
Ins Owners11.06%
Ins Owner Change27.21%
Market Cap13.02M
Analysts0
Price Target5.1 (191.43%)
Short Float %0.63%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.33
P/FCF N/A
P/OCF N/A
P/B 1.85
P/tB 1.85
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.4
BVpS0.95
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.1%
ROE -27.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC9.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.67%
EPS Next Y102.28%
EPS Next 2Y39.8%
EPS Next 3Y31.06%
EPS Next 5YN/A
Revenue 1Y (TTM)33.79%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%630.77%
Revenue Next Year10.64%
Revenue Next 2Y25.41%
Revenue Next 3Y42.82%
Revenue Next 5YN/A
EBIT growth 1Y76.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.89%
OCF growth 3YN/A
OCF growth 5YN/A